1. Home /
  2. Healthcare

Healthcare

Jim Cramer: Centene Is in All the Big Medicare Markets

Jim Cramer: Centene Is in All the Big Medicare Markets

Centene is in all the big Medicare markets, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer, who interviewed CEO Michael Niedorff on Friday's edition of CNBC's "Mad Money."

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Jim Cramer and our other experts look at President Trump, the new tariffs on China, Walgreens stock, and Etsy.

Creates Act Clears Committee Vote, Could Ease Way for Generic Drugmakers

Creates Act Clears Committee Vote, Could Ease Way for Generic Drugmakers

While the CREATES ACT passed out of committee in the Senate, Senator Orrin Hatch, who helped pave the way for generic drugs in the U.S,,voted against the measure.

Stryker Says Not in Talks to Buy Boston Scientific

Stryker Says Not in Talks to Buy Boston Scientific

The medical device firm issues an 8-K filing on the heels of a media report earlier this week that said it recently made a takeover approach to Boston Scientific.

Eli Lilly, AstraZeneca Shares Fall After Halting Alzheimer's Drug Test

Eli Lilly, AstraZeneca Shares Fall After Halting Alzheimer's Drug Test

The biopharmaceutical companies saw their stocks drop amid fallout of failed Alzheimer's drug trials.

Can Legal Cannabis Help Slow the Opioid Drug Epidemic in the U.S.?

Can Legal Cannabis Help Slow the Opioid Drug Epidemic in the U.S.?

More research is needed, but medical experts agree that cannabis plants have immense potential to slow opioid drug overdoses, which claim 115 lives every day in the U.S.

Sanofi, Merck and J&J Tout Lower Drug Prices

Sanofi, Merck and J&J Tout Lower Drug Prices

While a handful of drug companies say their average net prices have dropped, FDA Commissioner Scott Gottlieb announces a plan to encourage drug competition in the face of monopolies.

The Future of Healthcare Will Have You in Control for a Change: Cigna CEO

The Future of Healthcare Will Have You in Control for a Change: Cigna CEO

Cigna CEO David Cordani is game on in trying to shape the future of healthcare. He talks with TheStreet on where he thinks things are headed.

Merck Higher on Lung Cancer Data

Merck Higher on Lung Cancer Data

The drugmaker's presentations at ASCO's annual meeting included data on Keynote-407, which Credit Suisse analyst Vamil Divan described as a 'clear positive.'

With 'Right to Try' Now Law, FDA Must Find a Way to Make It Work

With 'Right to Try' Now Law, FDA Must Find a Way to Make It Work

The Right to Try Act has been championed as a way to give seriously ill patients more options, but the author of bill says it is about getting FDA out of 'people's lives.'